NCT06865222

Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation

Variable Pulse Transcranial Magnetic Stimulation for Treatment of Post COVID Syndrome

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).

Conditions

• Post COVID-19 Condition

Interventions

Type	Name	Description
PROCEDURE	Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks	The Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) will be administered through an FDA-approved Transcranial Magnetic Stimulation (TMS) medical device. Results of the baseline EEG will be uploaded to NoetherTech's EMBP software on the Mayo Clinic campus, and transferred to Noethertech servers for TMS parameter determination TMS treatment will be one 30 min session per day, 5 days per week (Monday-Friday), for 2 weeks.
PROCEDURE	Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks	The Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) will be administered through an FDA-approved Transcranial Magnetic Stimulation (TMS) medical device. Results of the baseline EEG will be uploaded to NoetherTech's EMBP software on the Mayo Clinic campus, and transferred to Noethertech servers for TMS parameter determination TMS treatment will be one 30 min session per day, 5 days per week (Monday-Friday), for 4 weeks.

Timeline

• Start date: 2025-07-22
• Primary completion: 2027-01-01
• Completion: 2027-04-01
• First posted: 2025-03-07
• Last updated: 2025-08-14

Locations

1 site across 1 country: United States